Hiroyoshi Hayakawa

T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2.

H. Mukae, S. Kohno, T. Miyazaki, 2016, The Journal of antimicrobial chemotherapy.

Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats

A. Tsuji, Kyoko Takagi, Y. Kawamura, 2002, The Journal of pharmacy and pharmacology.

T-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast

A. Kimura, Toshinari Takahashi, N. Nomura, 2012, Antimicrobial Agents and Chemotherapy.

Uptake of T-2307, a novel arylamidine, in Candida albicans.

N. Nomura, H. Nishikawa, J. Mitsuyama, 2010, The Journal of antimicrobial chemotherapy.

Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms

S. Ikushiro, T. Sakaki, M. Onoda, 2011, Drug Metabolism and Disposition.

Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.

S. Furubo, K. Kizawa, T. Sanzen, 2002, The Journal of toxicological sciences.

[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].

Y. Kawamura, Shozo Nakamura, M. Miyazaki, 2002, The Japanese journal of antibiotics.

The Formation of Desethyl‐Piperacillin from Piperacillin by Human Liver S9 in vitro

C. Green, M. Komuro, Hiroyoshi Hayakawa, 1997, Biopharmaceutics & drug disposition.

Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and an interspecies scaling of pharmacokinetic parameters.

A. Tsuji, H. Kato, Hiroyuki Fukumoto, 2003, Drug metabolism and disposition: the biological fate of chemicals.